Error: Could not add to watchlist. X

AXA Framlington Biotech Fund

+ Watchlist
FRABIOI:LN
121.80
GBp
4.30
3.41%
As of 12:59 AM EST on 2/9/2016.
Fund Type
Unit Trust
52Wk Range
121.80 - 193.50
1 Yr Return
-22.52%
YTD Return
-26.45%
Previous Close
126.10
52Wk Range
121.80 - 193.50
1 Yr Return
-23.11%
YTD Return
-26.45%
Fund Type
Unit Trust
Objective
Health Care Sector
Asset Class Focus
Equity
Geographic Focus
Global
NAV (on 02/09/2016)
121.8
Total Assets (m GBP) (on 02/09/2016)
506.216
Inception Date
11/26/2001
Last Dividend (on 09/01/2015)
-
Dividend Indicated Gross Yield
-
Fund Managers
LINDEN THOMSON
Front Load Fee
5.50%
Back Load Fee
0.00%
Redemption Fee
0.00%
12b-1 Fee
-
Current Mgmt Fee
1.75%
Expense Ratio
1.95%
Top Fund Holdings
Name Position Value % of Fund
Biogen Inc 350.49 k 72.87 m 9.90
Celgene Corp 878.45 k 71.40 m 9.70
Gilead Sciences Inc 986.07 k 67.72 m 9.20
Alexion Pharmaceuticals Inc 346.83 k 44.90 m 6.10
Vertex Pharmaceuticals Inc 422.35 k 36.07 m 4.90
Amgen Inc 320.70 k 35.33 m 4.80
Regeneron Pharmaceuticals Inc 89.90 k 33.12 m 4.50
Incyte Corp 380.02 k 27.97 m 3.80
BioMarin Pharmaceutical Inc 362.35 k 25.76 m 3.50
Illumina Inc 197.76 k 25.76 m 3.50
Profile
AXA Framlington Biotech Fund is an authorized unit trust incorporated in the United Kingdom. The aim of the Fund is to provide long-term capital appreciation The Fund will invest principally in equity securities of companies in the biotechnology, genomic and medical research industries worldwide.
ADDRESS
AXA Framlington Unit Management Ltd
7 Newgate Street
London EC1A 7NX
United Kingdom
PHONE
44-207-374-4100